Saniona AB (SANION)
Stockholm Exchange · Sweden · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 10.56 |
|---|---|
| 52-week range | 8.53 – 28.30 |
| Return, 1 month / 3 months | +10.6% / −19.7% |
| Return, 1 year / 3 years | −29.8% / +107.7% |
| Trend | Below its 200-day average |
| RSI (14) | 57 |
| Volatility (1 year) | 56.3% |
| Worst drawdown (1 year) | -67.2% |
| Average daily value traded | 4.91M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Saniona is a Swedish biotechnology company that researches and develops medicines, concentrating on drugs that act on ion channels, the proteins that control electrical signalling in cells. Its work centres on treatments for disorders of the central nervous system, including epilepsy, and it has also studied compounds for other conditions. The company carries out laboratory research and clinical development, working with partners in the pharmaceutical industry, and is based in Sweden.
On this site Saniona AB appears as a stock on the Stockholm Exchange (Sweden), code SANION, with prices in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Saniona AB (SANION) trades on the Stockholm Exchange in Sweden. It last closed at SEK 10.56 on 20 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 709 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 29.8% and over the last three months it fell 19.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 13 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -30.3% | ||
| From 52-week high | -61.6% | ||
| Momentum | 21 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -19.7% | ||
| 6-month return | -29.2% | ||
| 12-month return, skipping the last month | -36.5% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -67.2% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 4.91M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.0% |
|---|---|
| 1 month | +10.6% |
| 3 months | −19.7% |
| 6 months | −29.2% |
| 1 year | −29.8% |
| 3 years | +107.7% |
| 5 years | −0.2% |
Signals
| 50-day / 200-day average | 10.74 / 15.15 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.56 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.